{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T18:53:17Z","timestamp":1793731997932,"version":"4.6.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVES:<\/jats:title>\n            <jats:p>To develop and conduct preliminary testing of the Withdrawal Assessment Tool-Alpha 2 Agonist (WAT-A2A) to monitor dexmedetomidine and clonidine withdrawal symptoms in acutely ill children.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DESIGN:<\/jats:title>\n            <jats:p>Three-phase instrument development study. Phase 1: retrospective chart review of symptoms exhibited by children with documented dexmedetomidine withdrawal; phase 2: WAT-A2A instrument construction based on phase 1 data; and phase 3: prospective testing of the WAT-A2A in children weaning from alpha 2 agonists (A2As).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SETTING:<\/jats:title>\n            <jats:p>Academic free-standing children\u2019s hospital.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>PATIENTS:<\/jats:title>\n            <jats:p>Acutely ill children weaning from at least 5 days of dexmedetomidine. Excluded were children concurrently weaning other sedatives.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>INTERVENTIONS:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>MEASUREMENTS AND MAIN RESULTS:<\/jats:title>\n            <jats:p>Phase 1: In 83 of 303 children weaning from at least 5 days of dexmedetomidine who had clinician documentation and were managed for A2A withdrawal, 88% (<jats:italic toggle=\"yes\">n<\/jats:italic> = 72) exhibited at least a 20% increase in heart rate (HR), 83% (<jats:italic toggle=\"yes\">n<\/jats:italic> = 69) exhibited agitation or change in usual state behavior, 46% (<jats:italic toggle=\"yes\">n<\/jats:italic> = 38) exhibited at least a 20% increase in diastolic blood pressure (DBP), and when documented, 56% (27\/48) exhibited tremors during their A2A withdrawal episode. Phase 2: The WAT-A2A was constructed, based on phase 1 data, and includes four items: HR, state behavior, DBP, and tremors. Phase 3: The WAT-A2A was tested and performed well in 82 children weaning from A2A. The total WAT-A2A score correlated with clinician subjective assessment of A2A withdrawal (Spearman correlation = 0.5; <jats:italic toggle=\"yes\">p<\/jats:italic> &lt; 0.001). Inter-rater agreement, comparing paired ratings of prospectively collected WAT-A2A data, indicated moderate inter-rater reliability.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSIONS:<\/jats:title>\n            <jats:p>Acutely ill children receiving sedation with an A2A for more than 5 days may develop physiologic dependence, requiring gradual dosing reductions. While further psychometric testing is advised, the WAT-A2A provides an objective instrument to help clinicians quantify dexmedetomidine withdrawal symptoms in acutely ill children may facilitate A2A weaning and limit unnecessary variation in practice.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000003645","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T15:00:12Z","timestamp":1733238012000},"page":"e67-e76","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Development and Preliminary Testing of the Withdrawal Assessment Tool-Alpha 2 Agonist: An Assessment Instrument for Monitoring Iatrogenic Withdrawal Symptoms in Children Receiving an Alpha-2 Agonist"],"prefix":"10.1097","volume":"26","author":[{"given":"Jean C.","family":"Solodiuk","sequence":"first","affiliation":[{"name":"Division of Pain Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Donado","sequence":"additional","affiliation":[{"name":"Division of Pain Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Wickerham","sequence":"additional","affiliation":[{"name":"Division of Pain Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Goodyear","sequence":"additional","affiliation":[{"name":"Division of Pain Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hayes","sequence":"additional","affiliation":[{"name":"Division of Pain Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Mortell","sequence":"additional","affiliation":[{"name":"Division of Pain Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine D.","family":"Greco","sequence":"additional","affiliation":[{"name":"Division of Pain Medicine, Department of Anesthesiology, Critical Care and Pain Medicine, Boston Children\u2019s Hospital, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha A. Q.","family":"Curley","sequence":"additional","affiliation":[{"name":"Department of Family and Community Health; School of Nursing, University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"R1-20250131","doi-asserted-by":"crossref","first-page":"e731","DOI":"10.1097\/PCC.0000000000002483","article-title":"Dexmedetomidine sedation in mechanically ventilated critically ill children: A pilot randomized controlled trial.","volume":"21","author":"Erickson","year":"2020","journal-title":"Pediatric Crit Care Med"},{"key":"R2-20250131","first-page":"125","article-title":"Sedative medications for critically ill children during and after mechanical ventilation: A retrospective observational study.","volume":"73","author":"Caldwell","year":"2020","journal-title":"Can J Hosp Pharm"},{"key":"R3-20250131","first-page":"453","article-title":"Prolonged dexmedetomidine infusion and drug withdrawal in critically ill children.","volume":"22","author":"Haenecour","year":"2017","journal-title":"J Pediatr Pharmacol Therapy"},{"key":"R4-20250131","first-page":"16","article-title":"Survey of the current use of dexmedetomidine and management of withdrawal symptoms in critically ill children.","volume":"24","author":"Thompson","year":"2019","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R5-20250131","doi-asserted-by":"crossref","first-page":"e467","DOI":"10.1097\/PCC.0000000000002325","article-title":"Dexmedetomidine for prolonged sedation in the PICU: A systematic review and meta-analysis.","volume":"21","author":"Daverio","year":"2020","journal-title":"Pediatric Crit Care Med"},{"key":"R6-20250131","first-page":"4","article-title":"Dexmedetomidine: Are there going to be issues with prolonged administration?","volume":"15","author":"Tobias","year":"2010","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R7-20250131","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PCC.0000000000002889","article-title":"Weaning dexmedetomidine in non-ICU areas: An implementation effort.","volume":"23","author":"Solodiuk","year":"2022","journal-title":"Pediatric Crit Care Med"},{"key":"R8-20250131","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/PCC.0000000000002873","article-title":"Society of Critical Care Medicine clinical practice guidelines on prevention and management of pain, agitation, neuromuscular blockade, and delirium in critically ill pediatric patients with consideration of the ICU environment and early mobility.","volume":"23","author":"Smith","year":"2022","journal-title":"Pediatr Crit Care Med"},{"key":"R9-20250131","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/phar.1559","article-title":"Transition from dexmedetomidine to enteral clonidine for ICU sedation: An observational pilot study.","volume":"35","author":"Gagnon","year":"2015","journal-title":"Pharmacotherapy"},{"key":"R10-20250131","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00134-011-2441-8","article-title":"Discontinuation of prolonged infusions of dexmedetomidine in critically ill children with heart disease.","volume":"38","author":"Burbano","year":"2012","journal-title":"Intensive Care Med"},{"key":"R11-20250131","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PCC.0000000000003376","article-title":"Dexmedetomidine withdrawal syndrome in children in the PICU: Systematic review and meta-analysis.","volume":"25","author":"Knapp","year":"2023","journal-title":"Pediatr Crit Care Med"},{"key":"R12-20250131","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1055\/s-0035-1559820","article-title":"Efficacy and safety of postoperative dexmedetomidine administration in infants and children undergoing cardiac surgery: A retrospective cohort study.","volume":"4","author":"Horvath","year":"2015","journal-title":"J Pediatr Intensive Care"},{"key":"R13-20250131","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.braindev.2016.02.003","article-title":"Potential risk factors for dexmedetomidine withdrawal seizures in infants after surgery for congenital heart disease.","volume":"38","author":"Takahashi","year":"2016","journal-title":"Brain Dev"},{"key":"R14-20250131","first-page":"542","article-title":"Clonidine for dexmedetomidine withdrawal in pediatric patients: A single center\u2019s experience.","volume":"24","author":"Beitz","year":"2019","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R15-20250131","first-page":"45","article-title":"Effects of clonidine on withdrawal from long-term dexmedetomidine in the pediatric patient.","volume":"20","author":"Lardieri","year":"2015","journal-title":"J Pediatr Pharmacol Ther"},{"key":"R16-20250131","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1111\/j.1368-5031.2005.00520.x","article-title":"Withdrawal syndrome following cessation of antihypertensive drug therapy.","volume":"59","author":"Karachalios","year":"2005","journal-title":"Int J Clin Pract"},{"key":"R17-20250131","first-page":"254","article-title":"Long-term outcomes and the post-intensive care syndrome in critically Ill children: A North American perspective.","volume":"8","author":"Woodruff","year":"2021","journal-title":"Children (Basel, Switzerland)"},{"key":"R18-20250131","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1097\/PCC.0b013e31818c8328","article-title":"The withdrawal assessment tool-1 (WAT-1): An assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients.","volume":"9","author":"Franck","year":"2008","journal-title":"Pediatr Crit Care Med"},{"key":"R19-20250131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/01.PCC.0000200955.40962.38","article-title":"State behavioral scale: A sedation assessment instrument for infants and young children supported on mechanical ventilation.","volume":"7","author":"Curley","year":"2006","journal-title":"Pediatr Crit Care Med"},{"key":"R21-20250131","article-title":"GEE: Generalized Estimation Equation Solver; R Package Version 4.13-26.","author":"Carey","year":"2023"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T17:04:18Z","timestamp":1738343058000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PCC.0000000000003645"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000003645","relation":{},"ISSN":["1529-7535","1947-3893"],"issn-type":[{"value":"1529-7535","type":"print"},{"value":"1947-3893","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]}}}